(Q38044254)

27 August 2017

title

Mechanisms and consequences of inflammatory signaling in the myocardium (English)

1 reference

27 August 2017

Jihyun Ahn

1

1 reference

27 August 2017

Jaetaek Kim

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current Hypertension Reports

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

510-516

1 reference

Heart failure-related hospitalization in the U.S., 1979 to 2004.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Int

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Long-term trends in the incidence of heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

From risk factors to structural heart disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Inflammation in myocardial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Inflammation and cardiac outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Variable phenotype in murine transverse aortic constriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Role of pattern-recognition receptors in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Toll-like receptors and myocardial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Protease-activated receptors and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Protease-activated receptor-2 activation improves efficiency of experimental ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Stimulus specificity of gene expression programs determined by temporal control of IKK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Multiple facets of NF-κB in the heart: to be or not to NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The fire within: cardiac inflammatory signaling in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Role of nuclear factor kappaB in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Mitogen-activated protein kinases in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The myocardial JAK/STAT pathway: from protection to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Interleukin 18 in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Regulation of the inflammatory response in cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Repair after myocardial infarction, between fantasy and reality: the role of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The multifunctional role of mTOR in innate immunity: implications for transplant immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The TSC-mTOR signaling pathway regulates the innate inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Myocardial repair/remodelling following infarction: roles of local factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Immune modulation in heart failure: past challenges and future hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Immunological mechanisms of pentoxifylline in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Lupus myocarditis: marked improvement in cardiac function after intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Fenofibrate attenuates endothelial monocyte adhesion in chronic heart failure: an in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Eplerenone inhibits tumour necrosis factor alpha shedding process by tumour necrosis factor alpha converting enzyme in monocytes from patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0309-0

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Increased expression of IL-6 and LIF in the hypertrophied left ventricle of TGR(mRen2)27 and SHR rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Monocyte suppressing action of fenofibrate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

Effects of methylprednisolone on the ischemic damage in patients with acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22986910

12 December 2020

10.1007/S11906-012-0309-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1010883850

0 references

Fatcat ID

release_yeltiivi7remzhdp2g3nhpju2e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yeltiivi7remzhdp2g3nhpju2e

24 November 2022

mapped directly with Wikidata item

1 reference